Coface FY-2023 results: net income at €240.5m and proposed dividend at €1.30 per share
Coface releases its FY-2023 financial results. Net income at €240.5m and proposed dividend at €1.30 per share
Turnover
€1,868m, up +6.0% at constant FX and perimeter and up +3.8% on a reported basis
- Trade credit insurance premiums increased by +5.4%; growth in client activities was negative in the second half of the year as a result of falling inflation and economic slowdown
- Client retention stood at a record high (93.1%); price effect was still negative (-1.9%) but stabilised in Q4-23
- Double digit growth in business information (+17.3% at constant FX and +23.4% in Q4 23) and debt collection, which is less cyclical. Factoring up by +2.6%
Net loss ratio
Net loss ratio at 37.7%, down by 2.0 ppts; net combined ratio at 64.3%, down by 3.3 ppts
- Gross loss ratio at 35.8%, up 0.3 ppt in a risk environment now close to historical averages
- Net cost ratio improved by 1.4 ppt at 26.6% reflecting high reinsurance commissions and business mix while we continue to invest
- Net combined ratio for Q4-23 at 59.0%, improving by 14.4 ppts on positive development in major claims
Net income (group share) of €240.5m, of which €50.8m in Q4-23. Annualised RoATE[1] at 13.4%
- Earnings per share reached €1.60
Coface continues to be backed by a solid balance sheet:
- Estimated solvency ratio at ~199%[2], above the upper end of target range (155% to 175%)
- Proposal to distribute a dividend[3] per share of €1.30 representing an 81% pay-out ratio
Renewal of the mandate of CEO, Xavier Durand , for 4 years and presentation of the next strategic plan "Power the Core" on 5 March 2024
Coface CEO's statement
Coface delivered another strong year in a volatile and relatively weak global economic environment in 2023. Our turnover rose +6.0% at constant FX over the year due to an excellent first half, client retention which remained at record highs and an increase of service revenues. Business information revenue was up +23.4% in the last quarter, with FY growth of +17.3%, confirming this activity's growth potential.
Annual net income under IFRS 17 was stable at €240m thanks to an excellent underwriting margin, leading to an annualised RoATE of 13.4% despite the negative impact of the fall of certain foreign currencies (
In an increasingly uncertain environment, Coface's teams confirmed their dedication to and their high level of expertise at the service of our clients.
We will propose a dividend of €1.30 per share at the Shareholders' Meeting, representing a payout ratio of 81%3. This is in line with the ambitions of the Build to Lead strategic plan - the objectives of which have all been met or exceeded. We will present our new strategic plan 2024 - 2027, on 5 March.
-
Unless otherwise indicated, change comparisons refer to the results as at
[1]Retuon average tangible equity
[2]This estimated solvency ratio is a preliminary calculation made according to Coface's interpretation of Solvency II regulations and using the Partial Internal Model. The final calculation may differ from this preliminary calculation. The estimated solvency ratio is not audited.
[3]The distribution proposal will be submitted to the Annual General Shareholders' Meeting to be held on
Attachments
Disclaimer


Avalon Saves Clients Millions, Sees Record Growth in 2023
Minneapolis-based UCare seeks growth, vying for Medicaid business in Kansas
Advisor News
- Nearly half of nonretirees doubt they will fully retire
- How much could failure to fund Social Security cost average Americans?
- How can more Americans achieve financial independence?
- Savers vs. spenders: How money management attitudes impact financial confidence
- Demonstrating the value of life insurance to Gen Z
More Advisor NewsAnnuity News
- DOL slams pension risk transfer lawsuit as ‘opportunistic’ litigation
- AM Best Affirms Credit Ratings of New York Life Insurance Company and Its Subsidiaries
- Advisors don’t have an annuity problem; they have an integration problem.
- Agentic AI is transforming insurance sales both for consumers and agents
- Canvas steps into the direct-to-consumer market that has yet to take off
More Annuity NewsHealth/Employee Benefits News
- New Findings from National Health Insurance Service Ilsan Hospital in the Area of Kidney Transplants Reported (Serum Proteomic Profiles of Microvascular Inflammation in Donor-specific Antibody-negative and C4d-negative in Kidney Transplantation): Transplant Medicine – Kidney Transplants
- AM Best Upgrades Credit Ratings for Delta Dental of California and Its Affiliates
- NEW DATA: RYAN MACKENZIE-BACKED HEALTHCARE CUTS CAUSE MORE THAN 13,000 PENNSYLVANIANS IN THE LEHIGH VALLEY TO DROP INSURANCE COVERAGE
- NEW DATA: ROB BRESNAHAN-BACKED HEALTHCARE CUTS CAUSE MORE THAN 11,600 PENNSYLVANIANS IN NEPA TO DROP INSURANCE COVERAGE
- Here’s what Rep. Goldman’s bipartisan bill for health insurance transparency does
More Health/Employee Benefits NewsLife Insurance News
- AM Best Affirms Credit Ratings of Bao Viet Insurance Corporation
- AM Best Affirms Credit Ratings of New York Life Insurance Company and Its Subsidiaries
- Agentic AI is transforming insurance sales both for consumers and agents
- USAA introduces Secure Start whole life program for children
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on South Korea’s Non-Life Insurance Market
More Life Insurance News